Rohan Wijesurendra
MB BChir MA (Cantab) DPhil (Oxon) MRCP FESC
Senior Clinical Research Fellow
Rohan Wijesurendra studied medicine at Cambridge University with several prizes and scholarships including Distinctions in all parts of the Final MB and the George Peter Baker prize for the best performance across the university in the written component of the Final MB examinations. He moved to Oxford for postgraduate medical training and higher specialist training in Cardiology. He was awarded a DPhil in Cardiovascular Medicine in 2018, following a period of research using multi-parametric cardiovascular magnetic resonance techniques to investigate the left ventricular phenotype in patients with atrial fibrillation. For aspects of this work, he also received the Young Investigator Award in Clinical Science of the European Society of Cardiology and the Melvin Judkins Young Investigator Award of the American Heart Association.
Rohan was appointed as Clinical Research Fellow at CTSU in 2021, and became Senior Clinical Research Fellow in 2023. He also works as an honorary consultant cardiologist and electrophysiologist at Oxford University Hospitals NHS Foundation Trust. His research combines large-scale trials in cardiovascular disease with more mechanistic clinical studies; he has particularl interests in atrial fibrillation and cardiometabolic risk factor modification. He continues to undertake a wide gamut of clinical work in cardiac rhythm management, including diagnostic electrophysiology, simple and complex ablation, and device implantation and extraction. In addition to his research and clinical commitments, he regularly undertakes undergraduate and postgraduate teaching, and is Stipendiary Lecturer in Clinical Medicine at St John’s College.
Recent publications
-
Making the Right Diagnosis: Slowly but Surely.
Journal article
Gajendragadkar PR. et al, (2023), Circulation, 148, 1814 - 1818
-
Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial.
Journal article
Wijesurendra RS. et al, (2023), Eur Heart J
-
What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria.
Journal article
Dasí A. et al, (2023), J Physiol
-
Editorial Expression of Concern: Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance.
Journal article
Liu A. et al, (2023), J Cardiovasc Magn Reson, 25
-
Reduced Left Atrial Rotational Flow Is Independently Associated With Embolic Brain Infarcts.
Journal article
Spartera M. et al, (2023), JACC Cardiovasc Imaging